Development of Nomogram to Non-steroidal Antiandrogen Sequential Alternation in Prostate Cancer for Predictive Model-Reference-Cited by-同舟云学术

Development of Nomogram to Non-steroidal Antiandrogen Sequential Alternation in Prostate Cancer for Predictive Model

Published:2014-02-09 Issue:3 Volume:44 Page:263-269
ISSN:1465-3621
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Kamiya Naoto,Suzuki Hiroyoshi,Nishimura Kensaku,Fujii Motohiro,Okegawa Takatsugu,Matsuda Tadashi,Morita Tatsuo,Takihana Yoshio,Ozono Seiichiro,Namiki Mikio,Matsubara Akio,Ichikawa Tomohiko,Miki Tsuneharu

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/44/3/263/11687210/hyt230.pdf

Reference26 articles.

1. Clinicopathological statistics on registered prostate cancer patients in Japan: 2000 report from the Japanese Urological Association;Cancer Registration Committee of the Japanese Urological Association;Int J Urol,2005

2. Current topics and perspectives relating to hormone therapy for prostate cancer;Suzuki;Int J Clin Oncol,2008

3. Prostate specific antigen decline after antiandrogen withdrawal: the FLT withdrawal syndrome;Kelly;J Urol,1993

4. Secondary hormonal therapy for advanced prostate cancer;Lam;J Urol,2006

5. Hormone-refractory (D3) prostate cancer: refining the concept;Scher;Urology,1995

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive Models for Assessing Patients’ Response to Treatment in Metastatic Prostate Cancer: A Systematic Review;European Urology Open Science;2024-05

2. A case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure;NAGOYA J MED SCI;2019

3. Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: a retrospective study;International Journal of Clinical Oncology;2019-02-11

4. Alternative Antiandrogen Therapy for CRPC;Hormone Therapy and Castration Resistance of Prostate Cancer;2018

5. Tools for Predicting Clinical and Patient-reported Outcomes in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Systematic Review of Prognostic Accuracy and Validity;Clinical Genitourinary Cancer;2017-12